{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T19:51:41Z","timestamp":1782417101530,"version":"3.54.5"},"reference-count":0,"publisher":"AVES YAYINCILIK A.\u015e.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["EJR"],"abstract":"<jats:p>Abstract\n\t\u00a0\n\n\tThe use of anti-tumor necrosis factor alpha (anti-TNF-\u03b1) agents has increased during the past decade in rheumatology practice. Opportunistic infections have been reported with anti-TNF-\u03b1 agents in clinical trials and post-marketing usage. Aspergillus infection is a rare opportunistic infection that is associated with immunosuppression, and there are reported cases of pulmonary aspergillosis in various rheumatic diseases treated with anti-TNF-\u03b1 agents. Here, we present the first case of pulmonary aspergillosis associated with infliximab treatment in a patient with Still\u2019s disease. \n\n\t\u00a0\n\n\tCite this article as: \u015eeyho\u011flu E, Erden A, K\u0131l\u0131\u00e7 L, Karada\u011f \u00d6, Ar\u0131kan Akda\u011fl\u0131 S, Akdo\u011fan A, et al. Pulmonary aspergillosis after treatment with infliximab\u00a0in Still\u2019s disease and a literature review of Still\u2019s disease and pulmonary aspergillosis. Eur J Rheumatol 2018; 5: 75-8.<\/jats:p>","DOI":"10.5152\/eurjrheum.2016.15081","type":"journal-article","created":{"date-parts":[[2017,2,23]],"date-time":"2017-02-23T07:32:57Z","timestamp":1487835177000},"page":"75-78","source":"Crossref","is-referenced-by-count":5,"title":["Pulmonary aspergillosis after treatment with infliximab in Still\u2019s disease and a literature review of Still\u2019s disease and pulmonary aspergillosis"],"prefix":"10.5152","volume":"5","author":[{"given":"Emrah","family":"\u015eeyho\u011flu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abd\u00fclsamet","family":"Erden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levent","family":"K\u0131l\u0131\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6mer","family":"Karada\u011f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevtap","family":"Ar\u0131kan Akda\u011fl\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Akdo\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umut","family":"Kalyoncu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3111","published-online":{"date-parts":[[2019,9,3]]},"container-title":["European Journal of Rheumatology"],"original-title":[],"link":[{"URL":"https:\/\/www.eurjrheumatol.org\/index.php\/pub\/article\/download\/237\/237","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T07:26:32Z","timestamp":1753773992000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurjrheumatol.org\/index.php\/pub\/article\/view\/237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,3]]},"references-count":0,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,9,3]]}},"URL":"https:\/\/doi.org\/10.5152\/eurjrheum.2016.15081","relation":{},"ISSN":["2148-4279"],"issn-type":[{"value":"2148-4279","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,3]]}}}